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Abstract
Background: The use of apps for the treatment of depression shows great promise. However, there is uncertainty regarding the
alignment of publicly available apps for depression with clinical guidance, their treatment fidelity and evidence base, and their
overall safety.
Objective: Built on previous analyses and reviews, this study aims to explore the treatment and safety issues of publicly available
apps for depression.
Methods: We conducted a content analysis of apps for depression in the 2 main UK app stores (Google Play and Apple App
Store). App store listings were analyzed for intervention content, treatment fidelity, and fit with the National Institute for Health
and Care Excellence (NICE) guidelines for the treatment of depression in adults.
Results: A total of 353 apps for depression were included in the review. App descriptions reported the use of 20 treatment
approaches and 37 treatment strategies. Many apps used transdiagnostic (155/353, 43.9%) and multitheoretical interventions to
treat multiple disorders including depression. Although many interventions appeared to be evidence-informed, there were issues
with treatment fidelity, research evidence, and fit with clinical guidelines. None of the apps fully aligned with the NICE guidelines
for depression.
Conclusions: App developers have adopted many evidence-informed treatments in their interventions; however, more work is
needed to improve clinical validity, treatment fidelity, and the safety of apps. We urge developers to consult relevant guidelines
and standards, and to engage in reflective questioning on treatment and safety to address these issues and to improve treatment
content and intervention design.
(JMIR Form Res 2020;4(11):e14988) doi: 10.2196/14988
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Introduction
Management and Treatment of Depression
Depression is an affective disorder characterized by persistent
low mood; loss of interest or pleasure; increased negative
thoughts and feelings; and associated emotional, cognitive,
physical, and behavioral difficulties [1-3]. Within the United
Kingdom, the National Institute for Health and Care Excellence
(NICE) seeks to improve outcomes for people using the National
Health Service (NHS) and other public health services through
the provision of evidence-based guidance, quality standards,
and performance metrics. NICE guidelines for the treatment
and management of depression in adults [4,5] recommend a
stepped care approach of clinical and cost-effective
interventions. Following early intervention through screening,
assessment, and psychoeducation, first-line treatments for
subthreshold or mild to moderate depression include
low-intensity psychosocial interventions, specifically guided
self-help based on cognitive behavioral therapy (CBT) or group
physical activity programs. Persons with less severe depression
who decline or do not respond well to these interventions should
be offered high-intensity psychological
interventions—specifically CBT, interpersonal therapy (IPT),
behavioral activation, or behavioral couples therapy—or
antidepressants. If declined, individuals may be offered
counseling or short-term psychodynamic psychotherapy.
For moderate to severe depression, NICE advises a combination
of antidepressants and high-intensity interventions (CBT or
IPT), with relapse prevention consisting of antidepressants and
CBT or mindfulness-based cognitive therapy (MBCT). Complex
and severe cases of depression receive the highest level of care,
which may include multidisciplinary care, specialist mental
health services, and crisis resolution.
Network meta-analysis of clinical evidence for the treatment of
depression in adults found self-help with support to be more
effective than psychoeducation and self-help without support
[4]. These self-help interventions included (from better to worse
outcomes): computerized psychodynamic therapy with support,
computerized CBT with support, computerized behavioral
activation with support, computerized CBT without support,
psychoeducational website, and computerized mindfulness
intervention. Although the 2018 NICE draft guidelines did not
specifically recommend mobile apps, their 2019 guidelines for
depression in children and young people [6] advised the use of
digital CBT in cases of mild depression. This included CBT
delivered via a computer, tablet, or phone.
Building on this guidance, NHS England and NICE developed
a digitally enabled therapy assessment program aimed at
evaluating the use of digital therapy products in the NHS
Improving Access to Psychological Therapies (IAPT) services
[7,8]. The program assessed 14 digitally enabled therapies (ie,
psychological interventions delivered on the web or through
apps with the support of a therapist). Of these, 6 targeted
depression in adults [9-15]. Digital therapies were assessed
based on 4 criteria: content, technical standards, clinical
effectiveness, and cost impact. In line with NICE guidance,
content assessment of digital therapies for depression evaluated
adherence to CBT and fit within a blended care model.
Following expert evaluations, only 3 digital therapies were
recommended for trialed use within IAPT services [11,12,14].
For those not recommended, treatment issues included
misalignment with the therapist-guided model of care [10], poor
user and treatment experiences [13], and incomplete treatment
content for depression because of the use of a transdiagnostic
approach [15]. Only one of the therapies offered a web- and
app-based program [12], with others being solely web-based.
Mobile Apps for Depression
The use of apps for the management of depression has shown
promise in providing accessible and low-cost mental health
interventions. Randomized controlled trials and reviews of apps
for depression have reported significant reductions in depressive
symptoms [16-22] and improvements in well-being [23]. There
is evidence of the use of apps for assessment and
psychoeducation [24], symptom tracking or mood monitoring
[19,24], cognitive training and problem solving [16], and a range
of treatment approaches, including CBT [19,22], behavioral
therapy (BT) and dialectical behavior therapy (DBT) [22],
mindfulness [19], and transdiagnostic approaches [17].
Although highlighting the potential of mobile mental health,
research cautioned that findings did not reflect apps available
to the public through the app marketplace. Torous et al [22]
showed that only one-third of apps for depression reviewed in
the literature were available for download in app stores, with
research reviews of the app marketplace uncovering a worrying
lack of evidence for most apps [25-27].
Content analyses and marketplace reviews of publicly available
apps found hundreds of apps marketed for depression. Given
the overwhelming number of apps, reviewers often limited
analyses to a subset [27-30] such as apps using specific
approaches [25,31,32]. The most common functionalities of
apps for depression included psychoeducation [25,27,29-31],
assessment [25,28,29,31], and symptom management [25,30,31].
Approximately one-third of apps for depression provided
therapeutic treatment [31] or interactive interventions [29]. CBT
apps for depression incorporated several strategies but were
criticized for overlooking treatment processes such as
challenging core beliefs and conceptualization in favor of
education, monitoring and tracking, and thought records [24,30].
Overall, the authors commented that although some apps seemed
to be evidence informed, reflecting some theoretical principles
and strategies, the apps did not demonstrate high fidelity to
evidence-based treatments such as CBT or BT [25,32] and
generally lacked evidence supporting use and efficacy
[21,23,25,27].
Reviews of publicly available apps for depression also
highlighted insufficiencies in the treatment and safety
information provided, including limited disclaimers [27], limited
encouragement for users to seek in-person care [29], and
inadequate reporting of affiliations or expert involvement
[31,32]. Reviews of the ethics of mobile mental health [33,34]
have also raised concerns with acceptance [35], risks and safety
of apps [36-47], and the poverty of evidence regarding benefits
and outcomes [36-40,42-46,48,49]. Therefore, there is
uncertainty as to how well apps for depression match existing
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clinical guidelines and recommendations, their treatment fidelity
(ie, adherence to components of a treatment orientation) and
evidence base, and their safety for use with or without support.
Overview of Study
This study builds on previous analyses and reviews to explore
treatment descriptions of publicly available apps for depression
and their alignment with clinical guidance as conveyed in app
store listings. The decision to review app listings rather than
downloaded apps reflects the lack of a comprehensive overview
of all treatment options marketed to the public through the
marketplace for apps for depression. Guided by NICE guidelines
and literature on the ethics and safety of mobile mental health,
we conducted content analysis of apps for depression listings
in the UK app marketplace. This study aims to answer the
following questions: (1) What treatment approaches and
strategies are named or described in app listings of apps for
depression? (2) Are treatment fidelity and evidence-informed
development evident in descriptions of apps for depression? (3)
Do descriptions of apps for depression reflect NICE guidelines
for the treatment and management of depression? We hope that
this study will advance research and discussion on the treatment
content and safety of publicly available apps for depression, in
particular their marketing to the public, fit with clinical
guidance, and discrepancies between public health digital
therapies and direct-to-consumer products. In doing so, we seek
to promote improved standards and best practices in the design
and marketing of mental health apps.
Methods
Sampling Methods
App search and data collection was conducted between October
and November 2018, guided by methods used by Shen et al [31]
and Stawarz et al [32]. The first step involved search of apps in
the 2 main UK app stores: Google Play and Apple App Store.
The initial search was performed using the search term
depression. For the review, apps for depression were defined
as apps with app store listings mentioning depression or
depressive symptoms. Apps were included in the review if they
met the following criteria: (1) app description included terms
depression, low mood or mood disorder, mood management,
negative thoughts, or distress and (2) app listing was in English.
Apps were excluded if they (1) did not mention depression or
depressive symptoms, (2) were for professional training, (3)
only provided quotes or wallpapers, or (4) were duplicates, that
is, copies of an app listed within the same app store. Duplicates
did not include free and paid versions of apps or apps listed in
both stores; in these cases, all relevant apps were included in
the review. Apps were also not excluded if they targeted another
mental health problem (eg, anxiety) once they mentioned
depression or depressive symptoms. This initial search returned
451 apps (296 in Google Play and 155 in Apple App Store). Of
these, 256 unique apps met the inclusion criteria (Figure 1).
A second search of the same app stores was performed using
the term mental health aimed at detecting apps for depression
that were not returned in the primary search. Finally, a hand
search of the same app stores for apps for depression that were
reported in previous research but not returned in the searches
was performed. These searches yielded an additional 97 eligible
apps. This resulted in a total of 353 unique apps for depression
being included in the analysis (Multimedia Appendix 1).
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Figure 1. Sampling flowchart.
Content Analysis
This study aims to explore treatment descriptions and fit with
clinical guidance of apps for depression, as evident in app store
listings and websites. Before the review, a list of variables was
compiled to extract data on app information, developer
information, treatment information, and usage. Data were
initially extracted from app listings and websites verbatim or
using yes or no coding to indicate the presence or absence of
variables. Throughout this process, coding was developed
iteratively as treatment information emerged. Treatment codes
were informed by NICE guidelines [4-6], literature on the
treatment of depression [50,51], and app reviews [25,29]. Final
coding is presented in Multimedia Appendix 2. Data extraction
and coding were led by the first author and revised through
group discussion until consensus was reached among all authors.
Descriptive statistics of the app data were computed using SPSS
version 25. Categorical variables were recoded numerically
before analysis. Spearman rank correlation coefficient was used
to explore associations within- and between-treatment
approaches and treatment strategies as part of the analysis of
treatment fidelity and evidence-informed interventions.
Chi-square tests were also performed to determine associations
between developer type and treatment variables.
Results
Treatment Descriptions of Apps for Depression
App store descriptions typically touted the suitability and
benefits of apps for depression or related difficulties. The
findings indicate that 28.3% (100/353) of apps targeted solely
depression, with most apps targeting depression alongside other
difficulties, notably anxiety and stress (Table 1). Just under
one-half (174/353, 49.3%) of all apps targeted multiple (4 or
more) disorders.
Less than one-third of apps (108/353, 30.6%) offered a
disorder-specific intervention, that is, an intervention designed
to treat a single mental health problem (eg, depression), whereas
43.9% (155/353) of apps described transdiagnostic interventions
treating multiple disorders using the same treatment content. A
further 25.5% (90/353) of apps reported treatment of multiple
disorders with varied content for each.
In this analysis, the treatment approach was defined as
theoretical or treatment orientation such as CBT, whereas
treatment strategies were the techniques employed in the
delivery of the intervention, such as cognitive reappraisal. Our
review identified 20 treatment approaches and 37 treatment
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strategies. For some apps, approaches (36/353, 10.2%) and
strategies (115/353, 32.6%) were not clearly presented. As per
previous research, the most common approach was
psychoeducation, with assessment and CBT frequently used
(Table 2). There was also a high use of complementary and
alternative therapies.
Table 1. Frequency of target disorders in apps for depression (N=353).
Apps, n (%)Target disorders
174 (49.3)Multiple
100 (28.3)Depression
34 (9.6)Depression and anxiety
27 (7.7)Depression, anxiety, and stress
4 (1.1)Suicide or self-injury
3 (0.8)Anxiety and stress
3 (0.8)Stress
2 (0.6)Depression, anxiety, and bipolar disorder
1 (0.3)Anxiety
1 (0.3)Sleep
1 (0.3)Depression and stress
1 (0.3)Depression and bipolar disorder
1 (0.3)Depression, bipolar disorder, and schizophrenia
1 (0.3)Depression, anxiety, and trauma
Table 2. Treatment approaches of apps for depression (N=353).
Apps, n (%)aTreatment approach
141 (39.9)Psychoeducation
79 (22.4)Complementary and alternative therapies
66 (18.7)Screening or assessment
49 (13.9)Cognitive behavioral therapy
46 (13.0)Psychosocial
33 (9.4)Self-help
19 (5.4)Online therapy
13 (3.7)Positive psychology
12 (3.4)Exercise
5 (1.4)Dialectical behavior therapy
4 (1.1)Acceptance and commitment therapy
4 (1.1)Cognitive training
3 (0.9)Spiritual or faith based
2 (0.6)Behavioral therapy
2 (0.6)Eye movement desensitization and reprocessing
1 (0.3)Interpersonal therapy
1 (0.3)Mindfulness-based cognitive therapy
1 (0.3)Motivational interviewing
1 (0.3)Neurostimulation
1 (0.3)Problem-solving therapy
aPercentages do not add up to 100% because some apps use multiple approaches.
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Our review found that 59.2% (209/353) of app listings reported
only 1 identifiable treatment approach, with others describing
combinations of 2 to 6 approaches (n=317 [missing cases
excluded]; mean 1.53, SD 0.92; mode 1). There were 59 unique
combinations of approaches. This is captured in Figure 2, which
maps significant positive associations between treatment
approaches, providing insight into the most commonly used
treatment combinations (the correlation table is given in
Multimedia Appendix 3). Despite the low frequency of some
approaches, these results illustrate patterns in the treatments
used, such as combinations of different cognitive approaches
(acceptance and commitment therapy, CBT, and DBT).
Figure 2. Significant associations between treatment approaches in apps for depression (Spearman rank correlation coefficients, P<.01). ACT: acceptance
and commitment therapy; BT: behavioral therapy; CBT: cognitive behavioral therapy; DBT: dialectical behavioral therapy; EMDR: eye movement
desensitization and reprocessing; IPT: interpersonal therapy; PST: problem-solving therapy.
Eclecticism in treatment was also evident in the variety of
treatment strategies (Table 3). Overall, 22.9% (81/353) of apps
described only 1 identifiable treatment strategy, with the
remaining naming between 2 and 16 strategies (n=238 [missing
cases excluded]; mean 2.53, SD 1.82; mode 1). There were 112
unique combinations of strategies (Multimedia Appendix 1).
These strategy combinations are illustrated in Figure 3, which
captures the significant positive associations between the most
commonly identified strategies (n>9; the correlation table is
given in Multimedia Appendix 4). As with the treatment
approaches, patterns emerged in the reported use of treatment
strategies. Such patterns suggest evidence-informed
development, as seen with the associations between the use of
emotional awareness, cognitive reappraisal, behavioral
activation, and monitoring and tracking, which are all emotion
regulation techniques typically employed in treatments for
depression, such as CBT and evidence-based multitheoretical
[50] and transdiagnostic [51] approaches.
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Table 3. Treatment strategies of apps for depression (N=353).
Apps, n (%)aTreatment strategies
109 (30.9)Monitoring and tracking (including diaries)
54 (15.3)Mindfulness or meditation
41 (11.6)Emotional awareness
41 (11.6)Relaxation
34 (9.6)Peer support
29 (8.2)Sound or music
28 (7.9)Connection to services
27 (7.7)Cognitive reappraisal
24 (6.8)Positive strategies
22 (6.2)Lifestyle or nutrition
22 (6.2)Skills building
17 (4.8)Medication management
16 (4.5)Behavioral activation
16 (4.5)Goal setting
16 (4.5)Hypnosis
15 (4.2)Crisis management
14 (4.0)Family support
13 (3.7)Emotion induction
10 (2.8)Yoga
5 (1.4)Distraction or grounding
4 (1.1)Acupressure
4 (1.1)Chatbot
4 (1.1)Self-compassion
3 (0.9)Bodily awareness
3 (0.9)Coaching
3 (0.9)Gamification
3 (0.9)Motivation enhancement
3 (0.9)Problem solving
2 (0.6)Cognitive bias modification
2 (0.6)Exposure
2 (0.6)Neuro-linguistic programming
1 (0.3)Acceptance
1 (0.3)Art therapy
1 (0.3)Chromotherapy
1 (0.3)Emotional freedom techniques
1 (0.3)Havening
1 (0.3)Transcranial direct current stimulation
aPercentages do not add up to 100% as some apps use multiple strategies.
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Figure 3. Significant associations between most common treatment strategies in apps for depression (Spearman rank correlation coefficients, P<.01).
CBT was associated with 13 of the 37 strategies (where
significant associations are P<.01), including cognitive
reappraisal, monitoring and tracking, and emotional awareness
(Table 4).
Mindfulness meditation was also often used in CBT apps;
however, only one app was identified as having a
mindfulness-based cognitive approach. Although these
associations suggested some evidence-informed development,
there were shortcomings in the reported use of these strategies
across CBT app listings. Specifically, except for monitoring
and tracking (41/49, 84%), less than half of all CBT app store
descriptions mentioned the use of these strategies (Multimedia
Appendix 5). Only 49% (24/49) CBT app listings described the
use of cognitive reappraisal, whereas 45% (22/49) mentioned
emotional awareness, 16% (8/49) used goal setting, and 14%
(7/49) reported the use of behavioral activation. In addition,
although a high number of CBT apps employed the use of
monitoring and tracking of mood, thoughts, and behaviors,
fewer reported the use of screening or assessment (8/49, 16%),
with only half of these app listings naming the measure used.
More often, CBT apps described the use of psychoeducation
(15/49, 31%), although this too was underutilized or
underreported.
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Table 4. Spearman rank correlation coefficients for cognitive behavioral therapy and all strategies (N=353).
P valueSpearman correlation coefficient, ρTreatment strategies
<.0010.62Cognitive reappraisal
<.0010.44Monitoring and tracking (including diaries)
<.0010.42Emotional awareness
<.0010.30Skills building
<.0010.29Relaxation
<.0010.23Goal setting
<.0010.22Mindfulness or meditation
<.0010.19Behavioral activation
<.0010.19Chatbot
<.0010.19Exposure
<.0010.19Self-compassion
.0040.15Positive strategies
.0080.14Coaching
.010.13Emotional freedom techniques
.010.13Havening
.03–0.12Connection to services
.030.12Crisis management
.09–0.09Sound or music
.140.08Cognitive bias modification
.140.08Neuro-linguistic programming
.140.08Yoga
.330.05Bodily awareness
.330.05Motivation enhancement
.330.05Problem solving
.37–0.05Hypnosis
.410.04Family support
.42–0.04Acupressure
.49–0.04Gamification
.690.02Distraction or grounding
.70–0.02Acceptance
.70–0.02Art therapy
.70–0.02Chromotherapy
.70–0.02Transcranial direct current stimulation
.80–0.01Medication management
.870.01Emotion induction
.880.008Peer support
.97–0.002Lifestyle or nutrition
Alignment With Clinical Guidelines on the Treatment
of Depression
In terms of adherence to clinical guidance, 67.1% (237/353) of
apps reported the use of at least one treatment approach
recommended in NICE guidelines for the treatment of
depression. Over half of all apps (181/353, 51.3%) described
an early intervention, namely, assessment or psychoeducation,
whereas 19.8% (70/353) of apps described the use of a
NICE-recommended psychological approach (ie, CBT, BT,
IPT, or web-based therapy).
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Although 13.9% (49/353) of apps adhered, to some extent, to
NICE’s recommendation for digital CBT, only 3.7% (13/353)
of CBT apps suggested use with in-person support (Multimedia
Appendix 5). Most CBT apps (37/49, 76%) appeared to use a
transdiagnostic approach to treat multiple disorders, including
depression. However, app descriptions did not specifically
address the treatment of comorbidities or the suitability for use
in complex cases. Moreover, only 18% (9/49) of CBT apps
appeared to have published research on use or outcomes. In
total, only 1 CBT app (MoodKit-Mood Improvement Tools)
was found to have both published research and advice to use
on its own or to enhance professional treatment. However, this
app was not marketed as a comprehensive CBT program but
rather as a mood improvement toolbox incorporating principles
and techniques of CBT. Overall, none of the app store
descriptions aligned with clinical guidance when assessed for
evidence of NICE-recommended evidence-based interventions,
therapist-guided models of care, and clinical effectiveness.
Further Treatment and Safety Issues
Overall, evidence of app use, safety, and outcomes was not
available for most apps (314/353, 89.0%). Despite this, most
app store descriptions (285/353, 80.7%) did not provide a
disclaimer regarding treatment, appropriate use, or limitations.
When provided, disclaimers ranged from caution that the app
does not replace traditional care, guidance to contact a health
care provider in cases of emergency, explicit statements of when
the app should not be used, or nonliability claims. Less common
but concerning were instances where app descriptions included
inaccurate information (15/352, 4.3%)—such as unsupported
claims that specific techniques (eg, daily journaling) were the
most effective in treating depression—or unsafe claims (8/352,
2.3%), for instance, unsupported statements that users would
not need to see a health care professional, would not experience
any risks or harms, or would experience immediate benefits.
Our review of the identified skills and expertise of developers
found that about one-third (117/353, 33.1%) of apps for
depression explicitly mentioned the involvement of health care
professionals, either in consultation or as a part of the
development team. As many as 57.8% (204/353) of apps
appeared to be developed by private entities without explicit
mention of the involvement of health care or other multisector
stakeholders. The importance of multidisciplinary development
teams was reflected in the absence of research conducted by
private entities without mention of stakeholder
involvement—specifically, all but one app, which reported
published (29/353, 8.2%) or unpublished (10/353, 2.8%)
research involved health care (22/39, 56%) or academia (17/39,
44%). Differences in developer type and treatment approach
were also noted. The reported use of psychoeducation was
associated with development by private entities without
stakeholders (χ²1=5.4; P=.02) but was less associated with
academia (χ²1=4.5; P=.04). Private entities (without
stakeholders) were also associated with the use of
complementary and alternative therapies (χ²1=4.7; P=.03) but
less associated with the use of CBT (χ²1=14.7; P<.001).
Comparatively, development teams with health care were
associated with the use of CBT (χ²1=20.3; P<.001), with 61%
(30/49) of CBT apps explicitly mentioning the involvement of
health care in app design or development.
Discussion
Principal Findings
The app marketplace offers potential users a range of apps
marketed for the treatment and management of depression. To
the best of our knowledge, this study is the first to provide a
comprehensive review of treatment descriptions of publicly
available apps for depression, exploring all reported treatment
approaches and strategies and the interrelations between them.
In doing so, we considered issues of treatment fidelity and the
quality of information presented to potential users to allow them
to make informed treatment decisions. This research is
particularly novel in its consideration of the alignment of
publicly available apps for depression with clinical guidelines
[4,5]. Our findings highlighted notable shortcomings in
treatment descriptions and clinical relevance, demonstrating
the need for improved regulation and evaluation of
direct-to-consumer mental health technologies.
Treatment Descriptions of Apps for Depression
The Popularity of Transdiagnostic Approaches
App store descriptions provided a range of treatment
information, with no standardized reporting of intervention
details, such as target disorder, intervention type, and treatment
approaches and strategies. As such, there was wide variation in
the amount and quality of treatment information provided by
different apps.
With regard to target disorder, less than one-third of apps
targeted solely depression, with the majority marketed for
multiple disorders. To cater to this multiplicity of mental health
problems, over 40% (155/353, 43.9%) of apps adopted
transdiagnostic approaches. Proponents of transdiagnostic
approaches [51-54] highlight the shared constructs and
mechanisms underlying many disorders, suggesting benefits in
the development and use of treatments across multiple mental
health problems. Sauer-Zavala et al [54] presented 3 categories
of transdiagnostic approaches, namely, universally applied
therapeutic principles, as seen in the application of CBT to treat
multiple disorders; modular treatments, whereby evidence-based
strategies are selected based on a client’s individual needs rather
than diagnosis; and shared mechanism treatment that targets
the underlying mechanisms in a class of disorders. There is
potential value in the development of transdiagnostic apps for
the treatment of depression [17]. However, as seen in the
categorizations of transdiagnostic approaches, such treatments
require a strong evidence base and rationale underlying
development and use. Developers seeking to design
transdiagnostic interventions should therefore consider the type
of transdiagnostic approach to be employed, the evidence base
underlying their intervention, and the evidence needed to justify
use and effectiveness with the target populations. Although
many apps appeared to adopt transdiagnostic approaches, this
was not explicitly stated in app listings, with none reporting use
of existing transdiagnostic treatment models [51,53].
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Treatment Approach and Evidence-Informed
Development
Developers typically described at least one treatment approach,
with several app descriptions reporting the use of 2 or more
approaches. Psychoeducation was the most popular approach,
as per previous reviews [25,27,29-31]. This is not surprising
given the relative ease of creating informational apps rather
than interactive interventions. More surprising was the frequency
of complementary and alternative approaches, which were more
common than assessment and CBT. This may also reflect the
ease in developing complementary and alternative app therapies,
which typically provided content such as sound, music, or
hypnosis or mindfulness meditation recordings. This was
supported by our findings that private entities without
stakeholder input were more likely to develop psychoeducation
and complementary and alternative app therapies rather than
interactive evidence-based interventions. Although
complementary and alternative therapies may offer
supplementary management of mental health difficulties,
research is needed to demarcate how and by whom such apps
should be used, the effectiveness and outcomes of their use for
depression, and fit within existing evidence-based treatment
models.
Our analysis also identified 37 unique treatment strategies, with
just under half of all apps describing the use of 2 or more
strategies. The plethora of strategy combinations suggested
idiosyncrasies in depression treatments or their marketing within
app stores. Without standardized reporting of treatment
approaches and strategies in app stores, potential users are left
to decipher app store descriptions for clues of the intervention
before download. Further research is therefore needed to
determine how accurately app interventions reflect their app
store descriptions and the range of unique combinations of
approaches and strategies in depression treatments as determined
by use of the apps.
This study provides novel insights into patterns of approaches
and strategies across all apps for depression, with significant
associations found between theoretically similar orientations
and methods. CBT apps for depression demonstrated significant
associations with several elements of CBT, including cognitive
reappraisal, monitoring and tracking, goal setting, behavioral
activation, emotional awareness, and skills building [25,55-57].
However, except for monitoring and tracking, less than half of
all CBT apps for depression reported use of these strategies.
Moreover, as noted by Huguet et al [25], other core elements
were either underreported or absent. Therefore, apps
demonstrated some treatment fidelity in their described
interventions; however, there remained significant gaps in
descriptions of theoretical principles and methods.
Eclecticism in Apps for Depression
Although many apps appeared to lack the core elements of
specific approaches, several apps reported the use of multiple
approaches and unique combinations of strategies. These
seemingly multitheoretical interventions are reflective of the
eclecticism in treatment seen in traditional mental health care
[58-61]. In real-world settings, decisions to offer eclectic or
integrative treatments require clinician judgment, knowledge,
and expertise to adapt established interventions to meet the
needs of individual cases. In this sense, integrative care may be
more complex than manualized treatments; therefore, they may
be more difficult to deliver effectively outside of in-person care.
Most mental health apps do not benefit from flexible clinical
decision making and in-the-moment expertise and thus require
clear information and evidence supporting their methods, use,
and outcomes. Therefore, the lack of research for most apps is
concerning and questions the validity of apps to deliver the
promised effects. Apps did not report use of multitheoretical
treatment models [50,58] but rather tended to cite benefits of
individual treatment approaches that were then combined in
their intervention. This design approach further supported the
suggestion that apps were evidence informed rather than
evidence based [25,27,32].
Alignment With Clinical Guidelines on the Treatment
of Depression
Another important consideration in assessing app validity and
suitability is their alignment with clinical guidance. For our
study, we focused on fit with NICE guidelines for the treatment
and management of depression in adults [4,5,7]. First, we
considered the reported use of NICE-recommended treatment
approaches that are not specific to mobile mental health. We
then considered alignment with NICE recommendations on
digital therapies for depression, specifically the use of CBT,
provisions for in-person support, and evidence of clinical
effectiveness. Superficially, approximately two-thirds of app
descriptions mentioned the use of treatment approaches outlined
in NICE guidelines, that is, at face value, most apps appeared
to incorporate aspects of clinically recommended treatments,
including psychoeducation, CBT, IPT, and BT [4,5,50,62,63].
A more detailed review of these apps is warranted to determine
fidelity to these approaches.
Specific reference to the use of mobile mental health within
NICE guidelines was reflected in recommendations for guided
self-help [4] and digital CBT [6,7]. Few apps fit this framework,
with only 13 apps offering CBT with suggested use with
practitioner support. Given the lack of evidence of clinical
effectiveness of these apps and pervasive shortcomings in
descriptions of core components of CBT, we did not find any
of the 353 app listings reviewed to fully align with treatment
criteria in NICE guidelines. In their present state, apps may be
more suited to provide supplement treatment for depression
through their focus on specific aspects of care, such as mood
tracking or goal setting. There were several strategies in apps
for depression that aligned with aspects of treatment in the NICE
framework, namely, apps offering monitoring and tracking,
mindfulness, peer support, crisis management, and medication
management. These strategies could act as tools to support
treatment within the stepped care model utilized by the NHS.
For example, monitoring and tracking apps could be utilized in
active monitoring, whereas medication management apps could
play an important role in increasing patient adherence to
pharmacological treatments [64,65]. NICE analysis of the
clinical effectiveness of mindfulness and peer support found
both offered potential benefits in treating and managing
depression but lacked enough evidence to support recommended
use [4]. Therefore, there is some justification in the use of these
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techniques to complement clinically effective treatments, as
determined by individual needs and preferences of users.
Implications for App Design, Development, and
Marketing
This study highlights notable shortcomings in the treatment
design and marketing of direct-to-consumer apps for depression.
There are persisting uncertainties regarding the treatment fidelity
and validity of these apps, with more research needed to support
the prevalent use of transdiagnostic and multitheoretical
approaches and complementary and alternative app therapies.
Our review shows a marked discrepancy between the digital
interventions recommended for use within the UK public health
system and apps for depression available to the public via the
app marketplace. Developers hoping to create digital therapy
products for use within the NHS should consult relevant
guidance [4-7,63,66], standards [67-70], and technical
specifications [71,72] to ensure that their app aligns with key
criteria, including the use of evidence-based treatments,
provisions for blended care, and evidence of clinical
effectiveness. Although developers not targeting the public
health system are not bound by these guidelines, we urge all
developers of apps for depression to be au fait with best practices
and to use these as a foundation in developing their digital
interventions and innovations. New treatment approaches and
methods are encouraged but must emerge from existing
knowledge, evidence, and best practices.
In creating and distributing mental health interventions, app
developers have a duty of care and responsibility for the content
they design and develop and how it is marketed to the public.
Regardless of the choice of treatment, developers and app stores
have an obligation to provide potential users with enough
information to help them make informed decisions regarding
an app’s suitability for their needs. Insufficient treatment
information and lack of research evidence impair the abilities
of potential users to make safe and informed choices and to
adequately prepare for risks and outcomes [44,73]. The lack of
evidence-based apps and the eclectic nature of some
interventions warrant greater safety considerations given the
use by potentially vulnerable persons. Efforts should be made
to assess and mitigate potential risks and harms, to protect
vulnerable groups, and to provide potential users with accurate
and transparent information regarding treatment, safety, and
outcomes. App stores should facilitate standardized reporting
of information about target users, target disorders, intervention
type, treatment approach, clinical evidence, compliance with
guidelines and standards, expected benefits and outcomes,
potential risks, safety and safeguarding, and general guidance
on use and stage in treatment. App listings should also clearly
outline the level of support provided and guidance on additional
support for optimal use and outcomes.
Developers are encouraged to embrace the complexities of
mobile mental health and to be innovative in their intervention
design and development through multidisciplinary collaboration
to produce clinically valid, effective, and safe treatments. To
facilitate this process, we present several reflective questions
for developers to engage with at the outset and throughout the
design and development of mental health technologies. These
questions aim to help developers to frame the rationale for their
intervention, to assess their strengths and limitations in the
design and development process, and to consider the treatment
and safety needs involved.
Reflective Questioning for the Design and Development
of Mobile Mental Health
Skills and Expertise
The following questions encourage reflection on the skills and
expertise of the development team, specifically their
competencies, multidisciplinary expertise, and user involvement:
• What knowledge and skills do you require for your project
to be a success?
• Are you part of a multidisciplinary team? Do you need
expert involvement?
• Is the development team sufficiently knowledgeable and
skilled in clinical care, psychological interventions,
theoretical principles, evidence-based practices, safety and
safeguarding, clinical guidelines and standards, ethics, and
codes of conduct?
• How will you involve user groups in planning, design,
development, and research?
Treatment Design
Questions on treatment design aim to assist developers in
considering the rationale for their app interventions, the intended
target disorders and users, and the appropriate treatment
orientation and strategies required to produce a quality app:
• Who are you developing the app for (consider
demographics, target disorder, mental health difficulties
and needs of users, and treatment histories and needs of
users)?
• Why have you selected that group of target users?
• What stage of treatment will your app address (consider
early intervention, first-line intervention, relapse prevention,
crisis management, etc)?
• Will your app span more than one treatment stage? How
will this be achieved through your intervention and app
design?
• Do you intend your app to be used as a standalone
intervention or supplementary to traditional care? How will
this be reflected in your intervention and app design?
• What level of support will you provide users (consider
connection to in-person services, crisis management,
blended care, etc)?
• Do you wish to develop a disorder-specific intervention,
or will you target multiple disorders using a transdiagnostic
approach?
• What type of transdiagnostic approach will you employ
(consider the 3 categories of transdiagnostic approaches
discussed by Sauer-Zavala et al [54])?
• Will your app intervention target the disorder (eg,
depression) or specific symptoms (eg, poor sleep)? How
will this be reflected in your intervention and app design?
• What is your treatment approach?
• Why have you chosen this treatment approach? How does
it align with your rationale, skills and expertise, and
intervention design?
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• How does your app intervention reflect evidence-based
treatments and clinical guidelines?
• For app interventions adapted from evidence-based
treatments (eg, CBT), will your app include all core
treatment elements? How will this be achieved through
your intervention and app design?
• What innovations will your app offer? Will these fit the
existing models of care?
• What would make this project a success for you?
Safety and Duty of Care
Developers should also reflect on the safety of mental health
apps and their role in designing, developing, and maintaining
safe mobile mental health:
• What do you consider to be your roles, responsibilities, and
duty of care as the developer of a mental health app? How
is this reflected in your app design, development, and
marketing?
• What values are important to you in the design,
development, and deployment of this technology?
• Has your app been designed, developed, and marketed with
safety in mind?
We encourage developers to use these reflections not only
throughout design and development but also in the deployment,
maintenance, and marketing of their apps.
Limitations
This study explores treatment descriptions and alignment with
the clinical guidance of apps in the UK app marketplace for
depression. It builds on previous content analyses to provide a
comprehensive overview of treatment content and clinical
validity as evident in app store descriptions; however, it is not
without limitations. First, we chose to conduct manual search
and data extraction of app listings rather than to use a script to
pull data from the app stores. Both methods have been used in
previous marketplace reviews and offer their own benefits and
limitations. Our decision to perform manual search reflects our
focus on the marketing of apps to the public, with this method
allowing for a first-person experience of searching, identifying,
and evaluating all returned apps. This meant that search
results—and therefore the final list of apps reviewed—may
differ slightly from those returned through a script. However,
we believe our findings benefited from the firsthand navigation
of the app marketplace and the challenges potential users may
encounter in their search for suitable apps.
Similarly, although a strength of the review was the inclusion
of all apps for depression, this limited our focus on app store
descriptions rather than downloaded apps. Our review captured
issues in the marketing and treatment descriptions of apps but
acknowledges that there may be discrepancies between app
store listings and in-app content. Therefore, there is scope for
further research to explore these issues through the use and
in-depth evaluation of apps. The iterative nature of the review
also allowed for rich data collection but limited rigorous research
methods such as blinded coding and interrater reliability.
Therefore, future reviews would benefit from the use of these
methods to strengthen the current findings.
Although the analysis was largely descriptive, correlation
calculations were performed to explore relationships within-
and between treatment approaches and strategies. The large
number of calculations may have resulted in increased type II
errors. To mitigate this, findings are reported as significant at
P<.01. We opted to not perform a correction calculation (eg,
the Bonferroni correction or false discovery rate), as we believe
it more beneficial for the development of future research to limit
the risk of type I errors, which would exclude potentially
interesting findings from the discussion. Results should be
interpreted with this in mind. Finally, this study was framed
and conducted within the United Kingdom. It is expected that
findings will be relevant to other health care markets; however,
country-specific practices may exist. The application of findings
should be done with this in mind.
Conclusions
This study advanced previous content analyses by providing a
comprehensive overview of treatment descriptions of publicly
available apps for depression. This is the first content analysis
of apps for depression to explore the full range of reported
treatment approaches and strategies and their fit with clinical
guidelines. App developers have adopted many evidence-based
treatments in their interventions; however, much work remains
in improving the validity, fidelity, clinical relevance, and safety
of apps offered directly to consumers. We encourage developers
to consult guidelines and standards and engage in reflective
questioning regarding treatment and safety. Developers are
urged to transfer this information to potential users through
transparent and sufficiently detailed app listings to allow users
to make informed decisions before app download and use.
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